Endocannabinoids mediate muscarinic acetylcholine receptor-dependent long-term depression in the adult medial prefrontal cortex Henry G. Martin1, 2, 3, Axel Bernabeu1, 2, 3, 4, Olivier Lassalle1, 2, 3, Clement Bouille1, 2, 3, Corinne Beurrier5, 2, Anne-Laure Pelissier-Alicot1, 2, 3, 6, Olivier J. Manzoni1, 2, 3* 1
INSERM U901, France, 2Aix-Marseille Université, France, 3INMED UMR_S 901, France,
4
APHM, CHU Conception, France, 5IBDM - CNRS 7288, France, 6APHM, CHU Timone Adultes, France Submitted to Journal: Frontiers in Cellular Neuroscience ISSN: 1662-5102
s i v o r P Article type: Original Research Article Received on: 21 Aug 2015 Accepted on: 09 Nov 2015
l a n io
Provisional PDF published on: 09 Nov 2015 Frontiers website link: www.frontiersin.org
Citation: Martin HG, Bernabeu A, Lassalle O, Bouille C, Beurrier C, Pelissier-alicot A and Manzoni OJ(2015) Endocannabinoids mediate muscarinic acetylcholine receptor-dependent long-term depression in the adult medial prefrontal cortex. Front. Cell. Neurosci. 9:457. doi:10.3389/fncel.2015.00457 Copyright statement: © 2015 Martin, Bernabeu, Lassalle, Bouille, Beurrier, Pelissier-alicot and Manzoni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
This Provisional PDF corresponds to the article as it appeared upon acceptance, after peer-review. Fully formatted PDF and full text (HTML) versions will be made available soon.
Frontiers in Cellular Neuroscience | www.frontiersin.org
s i v o r P
l a n io
1 2 3
Endocannabinoids mediate muscarinic acetylcholine receptordependent long-term depression in the adult medial prefrontal cortex
4 5 6
Authors: Henry G. S. Martin 1,2,3,#, Axel Bernabeu 1,2,3,6,#, Olivier Lassalle 1,2,3, Clément Bouille 1,2,3 , Corinne Beurrier 1,4 , Anne-Laure Pelissier-Alicot 1,2,3,5 and Olivier J. Manzoni 1,2,3*
7 8
#
These authors equally contributed to the study.
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
l a n io
Addresses: 1 Aix-Marseille Université, 2 INSERM, 3 INMED UMR_S 901, Marseille 13009, France, 4 CNRS IBDML UMR 7288 Marseille 13009, France, 5 APHM, CHU Timone Adultes, Service de Médecine Légale, 13005 Marseille, France 6APHM, CHU Conception, Service de Psychiatrie, 13005 Marseille, France.
s i v o r P
*Correspondence: Dr. Olivier Manzoni, INSERM U901, INMED, Parc Scientifique de Luminy, 163 Avenue de Luminy Marseille, Cedex 13273, France
[email protected]
24 25 26
Keywords: M1 muscarinic acetylcholine receptor, CB1 receptor, prefrontal cortex, long-term depression, eCB system, synaptic plasticity
27
1
28
Abstract
29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48
Cholinergic inputs into the prefrontal cortex (PFC) are associated with attention and cognition; however there is evidence that acetylcholine also has a role in PFC dependent learning and memory. Muscarinic acetylcholine receptors (mAChR) in the PFC can induce synaptic plasticity, but the underlying mechanisms remain either opaque or unresolved. We have characterized a form of mAChR mediated long-term depression (LTD) at glutamatergic synapses of layer 5 principal neurons in the adult medial PFC. This mAChR LTD is induced with the mAChR agonist carbachol and inhibited by selective M1 mAChR antagonists. In contrast to other cortical regions, we find that this M1 mAChR mediated LTD is coupled to endogenous cannabinoid (eCB) signaling. Inhibition of the principal eCB CB1 receptor blocked carbachol induced LTD in both rats and mice. Furthermore, when challenged with a sub-threshold carbachol application, LTD was induced in slices pretreated with the monoacylglycerol lipase inhibitor JZL184, suggesting that the eCB 2-arachidonylglyerol (2-AG) mediates M1 mAChR LTD. Yet, when endogenous acetylcholine was released from local cholinergic afferents in the PFC using optogenetics, it failed to trigger eCB-LTD. However coupling patterned optical and electrical stimulation to generate local synaptic signaling allowed the reliable induction of LTD. The light – electrical pairing induced LTD was M1 mAChR and CB1 receptor mediated. This shows for the first time that connecting excitatory synaptic activity with coincident endogenously released acetylcholine controls synaptic gain via eCB signaling. Together these results shed new light on the mechanisms of synaptic plasticity in the adult PFC and expand on the actions of endogenous cholinergic signaling.
49
s i v o r P
2
l a n io
50
Introduction
51 52 53 54
Acetylcholine is essential to learning and memory processes as well as synaptic plasticity in the CNS (Purves, 2001). The plethora of acetycholine physiological functions are underlined by the presence of both nicotinic ion channel receptors (nAChR) and muscarinic G-protein coupled receptors (mAChR).
55 56 57 58 59 60 61 62 63 64 65 66
In the perirhinal cortex, mAChRs of the M1 subtype underlie synaptic plasticity and recognition memory (Massey et al., 2001; Warburton et al., 2003). Likewise the prefrontal cortex is sensitive to regulation by M1 mAChRs, where in concert with nAChRs it modulates attention (Bloem et al., 2014; Hasselmo and Sarter, 2011; Klinkenberg et al., 2011). Furthermore, both pharmacological and genetic disruption of M1 mAChR signaling has been linked to deficits in learning and memory of prefrontal cortex dependent tasks (Anagnostaras et al., 2003; Barker and Warburton, 2009; Carballo-Márquez et al., 2007). Recent studies have identified an activitydependent long-term depression (LTD) in deep layers of the rat medial prefrontal cortex (mPFC) mediated by the M1 mAChR that may be relevant neurological disorders (Caruana et al., 2011; Ghoshal et al., 2015; Huang and Hsu, 2010). However, despite the importance of M1 mAChRs in the behavioral function and neuropathology of the mPFC, the expression mechanism of this LTD is unknown.
67 68 69 70 71 72 73 74 75 76 77 78 79
One of the major forms of LTD found at most excitatory circuits in the CNS is mediated by the endogenous cannabinoid (eCB) system (Heifets and Castillo, 2009; Katona and Freund, 2012). Retrograde eCB signaling typically requires the synaptic activation of postsynaptic G-coupled group I metabotropic glutamate receptors (mGluR) positively coupled to the phospholipase C (PLC) / intracellular Ca2+ pathways. Production and release of eCBs then acts at presynaptic CB1 receptors (CB1R) (Heifets and Castillo, 2009; Katona and Freund, 2012; Robbe et al., 2002) In the mPFC, strong evidence links disruption of eCB-LTD to neuropsychiatric diseases (Kasanetz et al., 2013; Lafourcade et al., 2007; Thomazeau et al., 2014). In addition to mGluR1/5, activation of other Gq/11 coupled receptors also produce eCBs and eCB dependent synaptic plasticity (Heifets and Castillo, 2009; Katona and Freund, 2012). Notably, activation of M1 mAChR triggers PLC dependent eCB release and can enhance short and long-term eCB plasticity at central synapses (Kim et al., 2002; Narushima et al., 2007; Ohno-Shosaku et al., 2003; Zhao and Tzounopoulos, 2011).
80 81 82 83 84 85 86
Here we tested the possibility that M1 mAChR LTD requires eCB signaling in the adult mPFC. We found that in both the rat and mouse mPFC blockade of the CB1R prevented carbachol induced M1 mAChR LTD. Furthermore subthreshold stimulation of mAChRs was converted to LTD when the degradation of the principal eCB 2-arachidonoylglycerol (2AG) was blocked. Finally in mice selectively expressing channelrhodopsin in cholinergic neurons, we show that light induced release of endogenous acetylcholine causes an LTD, mediated by M1 mAChRs and CB1Rs.
87
Materials & Methods
88 89 90
All mice and rats were group housed with 12 h light/dark cycles in compliance with the European Communities Council Directive (2010/63/EU) for the Care and Use of Laboratory Animals. Project ethical committee approval was sought from the Comité éthique de Provence and all
s i v o r P
3
l a n io
91 92 93 94 95 96 97
experiments were performed locally under European Union approval (agreement number: B 13055-19). Male C57Bl/6J, ChR2:ACh mice on a C57Bl/6J genetic background and Wistar rats were used. ChR2:ACh mice were generated by crossing Choline Acetyltransferase ChAT-IRESCre knock-in mice (ChATcre/cre mice, stock number: 006410) with LoxP-stop-ChR2(H134R)EYFP mice (Ai32 mice, stock number: 012569), where ChR2(H132R)-EYFP expression is restricted by a loxP-flanked STOP cassette (Madisen et al., 2012). All experiments were performed on adult animals; rats 3 – 4 months, mice 10 – 14 weeks.
98 99 100 101 102 103 104 105
Medial PFC expression of channelrhodopsin 2 in ChR2:ACh mice was confirmed by confocal microscopy. Direct fluorescent microscopy of the ChR2(H134R)-EYFP fusion protein showed that cholinergic afferents richly innervate the mPFC with corresponding channelrhodpsin expression in all cortical layers (Figure 1A). Furthermore we were able to identify a sparse population of bipolar cells that expressed channelrhodpsin locally (Figure 1B). These cells situated in layer 5 project neurites perpendicular to the cortical layer boundaries into both superficial and deep layers. We hypothesize these are previously reported cholinergic interneurons (Houser et al., 1985; Van der Zee and Keijser, 2011).
106
Slice Preparation
107 108 109 110 111 112 113 114
Rats and mice were anesthetized with isoflurane and decapitated according to institutional regulations. Brains were sliced (250 – 300 µm) in the coronal plane with a vibratome (Integraslice, Campden Instruments, Loughborough, UK) in a sucrose-based solution at 4°C (in mM: 87 NaCl, 75 sucrose, 25 glucose, 5 KCl, 21 MgCl2, 0.5 CaCl2 and 1.25 NaH2PO4). Slices were allowed to recover for 60 min at 32–35°C in artificial cerebrospinal fluid (aCSF) containing 126 mM NaCl, 2.5 mM KCl, 2.4 mM MgCl2, 1.2 mM CaCl2, 18 mM NaHCO3, 1.2 mM NaH2PO4 and 11 mM glucose, equilibrated with 95% O2 / 5% CO2. Slices were then maintained at 22 ± 2 °C until recording.
115
Electrophysiology
116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132
Whole-cell patch-clamp and extra-cellular field recordings were made from layer 5 pyramidal cells of the prelimbic cortex (Kasanetz et al., 2013; Lafourcade et al., 2007; Martin et al., 2015). For recording, slices were superfused (1.5 - 2 ml/min) with aCSF. All experiments were performed at 32 ± 2 °C. The recording aCSF contained picrotoxin (100 µM) to block GABA A receptors. To evoke synaptic currents, 100 – 200 µs stimuli were delivered at 0.1Hz through an aCSF-filled glass electrode positioned dorsal to the recording electrode in layer 5. Patch-clamp recordings were performed with a potassium gluconate based intracellular solution (values mM: 143 potassium gluconate, 3 NaCl, 1 MgCl2, 0.3 CaCl2, 1 EGTA, 0.2 cAMP, 0.3 NaGTP, 2 NaATP, 10 HEPES (pH 7.25), osmolarity 290 – 300 mol/L). Patch pipettes had a resistance between 3 and 5 MΩ. In all experiments cells were clamped at -70 mV (without junction potential correction). During recordings holding currents, series and input resistances and the membrane time constant (τ) were monitored. If the series resistance exceeded 25 MΩ or varied by > 20% during the experiment the recording was rejected. For extracellular field experiments, the recording pipette was filled with aCSF. The glutamatergic nature of the field excitatory postsynaptic potential (fEPSP) was systematically confirmed at the end of the experiments using the ionotropic glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2, 3-dione (CNQX, 20 µM), that specifically blocked the synaptic component without altering the non-synaptic
s i v o r P
4
l a n io
133 134
component (not shown). Example EPSPs and fEPSPs are single sweeps from the indicated time points, for clarity the stimulation artefact was removed from the fEPSP.
135
Optogenetics
136 137 138 139 140 141 142 143 144
A 473nm laser (Dragon Laser China) coupled to a 50 µm core glass silica optical fiber (ThorLabs) was positioned directly above the slice orientated at 30° approximately 350 µm from the recording electrode. Light intensity was calibrated to 2 mW at the fiber tip. At the site of recording discounting scattering a region of approximately 0.05 mm2 was illuminated that after power attenuation due to adsorption and scattering in the tissue was calculated as approximately 100 mW mm-2 (Yizhar et al., 2011). During repetitive stimulation this power intensity did not induce phototoxic effects (determined by field EPSP stability), yet was sufficient to reliably induce acetylcholine mediated LTD. Cholinergic fibers were excited by brief 5 ms pulses via a Master-8 pulse stimulator (AMPI).
145 146 147 148 149 150
A paired light EPSP protocol was developed to induce M1 mAChR LTD in ChR2:ACh mice. Local field EPSPs were first induced via a stimulation electrode positioned within the laser illuminated region surrounding the recording electrode. After a stable field EPSP baseline period, LTD was induced by pairing 2 pulses of light (50 ms interval) with a field EPSP co-incident with the second light pulse (Figure 5A, insert). Paired light EPSP stimulation was performed at 1 Hz for 1200 repetitions.
151
Data acquisition and analysis
152 153 154 155 156 157 158 159 160 161
Data was recorded on a MultiClamp700B amplifier, filtered at 2kHz, digitized (10kHz or 50kHz, DigiData 1440A), collected using Clampex 10.2 and analyzed using Clampfit 10.2 (Molecular Devices, Sunnyvale, USA). Analysis of both area and amplitude of fEPSPs was performed. The magnitude of LTD was calculated 30 – 40 minutes after the end of the induction protocol as percentage of baseline responses. Resultant changes in synaptic currents were analyzed with paired Student’s t-tests. The paired-pulse ratio (PPR) was calculated from the peak current of two closely spaced EPSCs (50 ms), such that the PPR = Peak 2 / Peak 1. Quoted PPR values are the average of 30 trials. The effect of group treatments on LTD were tested by one-way ANOVA and Holm-Sidak multiple comparisons test. N values represent individual animals. All values are given as mean ± standard error and statistical significance was set at *P < 0.05 and **P < 0.01.
162
Drugs
163 164 165 166
Drugs were added at the final concentration to the recording aCSF media. Picrotoxin was from Sigma (St. Quentin Fallavier, France); VU0255035, JZL184, AMG 9810, AM251, carbachol and pirenzepine dihydrochloride from Tocris, CNQX and D-AP5 was from the National Institute of Mental Health's Chemical Synthesis and Drug Supply Program (Rockville, MD, USA).
167
Results
168
M1 muscarinc acetylcholine receptor LTD is mediated by the CB1R in the adult rat PFC
169 170
Layer 5 mPFC pyramidal neurons in adult rodents are notable for expressing a prominent eCB mediated LTD in response to direct mGluR5 activation or patterned glutamatergic stimuli (Jung
s i v o r P
5
l a n io
171 172 173 174 175 176 177 178 179 180 181 182 183 184
et al., 2012; Lafourcade et al., 2007). This population of neurons also express M1 mAChRs that may couple to the same set of secondary messengers as the mGluR5 (Yamasaki et al., 2010). Given the role of acetylcholine in mPFC mediated tasks throughout life, we asked if M1 mAChR activation might also result in eCB-LTD in the adult rat mPFC. Recording field EPSPs from layer 5 of the mPFC, we first challenged acute brain slices with a brief (10 minutes, 10 µM) carbachol stimulation to test whether M1 mAChR LTD is expressed in these neurons (Figure 1A). As reported in juvenile rats (Caruana et al., 2011; Huang and Hsu, 2010), carbachol induced a rapid depression of responses that following washout incompletely recovered and stabilized at 76.8 ± 3.3 % (n = 17) of the baseline response. Notably, incubating the slices in the highly selective M 1 mAChR antagonist VU0255035 had no effect on the acute carbachol induced depression of responses, however after washout of carbachol responses recovered to baseline values (93.9 ± 6.4 %, n = 5). We compared individual field EPSPs before and 40 minutes after carbachol washout in control animals (Figure 1B). Carbachol treatment resulted in a highly significant depression of field EPSP responses (t(16) = 6.60, P < 0.001).
185 186 187 188 189 190 191 192 193 194 195 196
M1 mAChR and mGluR5 engage the same Gq/11 class of G-proteins and may activate 2-AG synthesis and CB1R mediated depression of synaptic transmission (Katona and Freund, 2012; Kim et al., 2002). Therefore in the presence of the selective CB1R antagonist AM251, we challenged layer 5 neurons to the same brief carbachol stimulation (Figure 1C). As before carbachol induced a strong acute depression of field EPSPs, however in the presence of the CB1R antagonist responses returned to baseline values after carbachol washout (93.3 ± 3.7 %, n = 8). Plotting of individual experiments indicated there was no significant difference in field EPSP responses after carbachol stimulation in the presence of AM251 (Figure 1D). Furthermore, compared to control experiments AM251 significantly interacted with the carbachol induced LTD in these neurons (2-way repeat measure ANOVA F(1,23) = 9.43, P = 0.006), which was due to an inhibition of the carbachol mediated LTD (P < 0.001, Holm-Sidak's multiple comparisons test).
197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213
In addition to the CB1R, the Transient Receptor Potential Vanilloid Type 1 (TRPV1) receptor is both expressed in the mPFC and activated by eCBs (Mezey et al., 2000). Through the mobilization of intracellular calcium stores, mAChR activation can enhance formation of the eCB anandamide leading to TRPV1 channel opening (van der Stelt et al., 2005). Therefore we asked if the TRPV1 receptor might also contribute to the induction of M1 mAChR LTD. Recording field EPSPs, we incubated layer 5 mPFC neurons in the TRPV1 antagonist AMG 9810 before again challenging with carbachol. However in contrast to the CB1R antagonist, AMG 9810 did not affect the induction of LTD (Figure 1E) and field responses remained significantly depressed compared to baseline (81.5 ± 6.1 %; t(8) = 2.78, P = 0.024). Furthermore, the carbachol LTD time course in the presence of AMG9810 broadly matched that of control neurons, indicating the TRPV1 receptor is not involved in M1 mAChR mediated LTD. Expressing the LTD as a percent depression of baseline values, we compared the carbachol effect across treatments and identified a significant effect (one-way ANOVA F(3,35) = 3.41, P = 0.028; Figure 1F). Treatment with either M1 mAChR antagonist or CB1R antagonist significantly reduced the induction of LTD compared to controls (VU0255035: P < 0.05; AM251: P < 0.05; Holm-Sidak's multiple comparisons test), however with TRPV1 receptor antagonist the percent LTD was not significantly changed.
s i v o r P
6
l a n io
214
M1 mAChR LTD is mediated by the action of the eCB 2-AG at the presynapse
215 216 217 218 219
CB1Rs in the CNS are principally activated by 2-arachidonoylglycerol (2-AG). In the classic model, 2-AG is synthesized in the post-synaptic neuron by diacylglycerol lipases before signaling in a retrograde direction to pre-synaptic CB1R which in turn depress neurotransmitter release (Heifets and Castillo, 2009). In the presynapse 2-AG is then rapidly degraded by resident lipases, principally by monoacylglycerol lipase (MAGL) (Lafourcade et al., 2007; Marrs et al., 2010).
220 221 222 223 224 225 226 227 228 229 230 231 232 233
If M1 mAChR LTD follows the classic model of CB1R mediated LTD it is expected that the resultant synaptic depression will have a presynaptic loci. To test this prediction we recorded the paired-pulse ratio from patched neurons during the induction of M1 mAChR LTD; any change in this measure would suggest the LTD involves a presynaptic component. Similar to field EPSP recordings, we found that patch-clamped neurons also undergo a robust LTD in response to carbachol challenge (10 minutes, 10 µM) resulting in a sustained depression in EPSC (67.2 ± 4.8 % of baseline, n = 7; Figure 3A). Initial responses from these neurons showed a weak pairedpulse facilitation in response to closely spaced EPSCs (1.66 ± 0.09, n = 9). However carbachol induced LTD resulted in sharp increase in the paired-pulse ratio that persisted and was concomitant to M1 mAChR LTD (Figure 3A). Comparing the paired-pulse ratio from individual neurons before and after M1 mAChR LTD, we found a significant increase in the paired-pulse ratio (Figure 3B; t(6) = 2.519, P = 0.045). Such an increase in paired-pulse facilitation is consistent with a reduction in neurotransmitter release probability and the expression of M1 mAChR LTD in the presynapse.
234 235 236 237 238 239 240 241 242
To investigate the role of 2-AG in M1 mAChR LTD, we took advantage of the sensitivity of CB1R mediated LTD to perturbations in the local concentration of 2-AG. Specifically, subthreshold stimulation protocols or pathological deficits in 2-AG eCB signaling may be restored to express LTD by manipulations that augment the synaptic concentration of 2-AG (Jung et al., 2012; Lafourcade et al., 2007; Marrs et al., 2010). Thus if a nominally subthreshold M1 mAChR activation is sensitive to manipulation of 2-AG concentration, this suggests M1 mAChR LTD engages the classic eCB-LTD model. We focused on the degradation of 2-AG, since it has previously been shown to have a critical role in eCB signaling and also due to the availability of highly selective drugs targeting MAGL (Long et al., 2009).
243 244 245 246 247 248 249 250 251 252 253
We first challenged mPFC neurons with different time periods of carbachol stimulation to determine a time – response profile for M1 mAChR LTD, whilst maintaining the same concentration of carbachol (10 µM). All intervals of carbachol challenge resulted in an acute depression of field EPSPs (Figures 2 & 3), however after 40 minutes washout responses recovered to baseline with a 5 minute challenge (97.8 ± 3.5 %, n = 6) or were progressively depressed depending on the duration of carbachol challenge (10 minutes: 76.8 ± 3.3 %, n = 17; 20 minutes: 55.3 ± 4.6 %, n = 3). Expressing responses as percent LTD we plotted the time – response profile for carbachol induced LTD and fitted a four-parameter logistic curve (Figure 3C, R2 = 0.53). The best-fit constants: LTDMAX 47.0 % (24.5 – 69.4, 95 % confidence interval), EC50 10.1 minutes (7.7 – 13.1, 95 % confidence interval), suggest that a 20 minute carbachol challenge is saturating.
254 255
Selecting the 5 minute subthreshold carbachol challenge, we repeated experiments in the presence of the selective MAGL inhibitor JZL184. In both conditions carbachol induced an acute
s i v o r P
7
l a n io
256 257 258 259 260 261 262
depression of field EPSPs from layer 5 neurons which was similar in both groups, however in the presence of JZL184 responses remained depressed after carbachol washout (Fig 3D). Average evoked responses 40 minutes after carbachol washout were significantly different between control and JZL184 treated neurons (Figure 2D, insert; t(8) = 2.94, P = 0.019). Furthermore compared to baseline, responses were significantly depressed (Figure 2E; 82.2 ± 3.8 % baseline; t(4) = 4.90, P = 0.016). Thus under otherwise subthreshold stimulation conditions, enhancement of the eCB system permits M1 mAChR LTD in mPFC neurons.
263
M1 mAChR LTD is recapitulated in adult mouse mPFC
264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280
Our findings and those of others suggest that M1 mAChR mediated LTD is a robust phenomenon found throughout development in the rat mPFC. However it is unclear if these findings can be generalized, especially in light of reported interspecies differences in cholinergic innervation and AChR synaptic modulation (Gil et al., 1997; Van der Zee and Keijser, 2011). Therefore we repeated our LTD experiments in the adult mouse mPFC. Recording layer 5 field potentials we challenged mPFC neurons with an identical 10 min carbachol (10 µM) protocol. Similar to the rat, carbachol induced a strong acute depression of field EPSPs, that after washout remain depressed and was absent in the presence of M1 mAChR antagonist pirenzepine (Figure 3A). Compared to baseline responses were significantly depressed 40 minutes after carbachol washout (86.1 ± 3.6 %; t(12) = 4.34, P = 0.001; Figure 3B). Furthermore in the presence of the highly selective M1 muscarinic receptor antagonist VU 0255,035 carbachol induced depression was also absent. Plotting individual experiments before and 40 minutes after carbachol washout in the presence of VU 0255,035, average responses were not different to baseline values (Figure 3C; 103.6 ± 2.6 %, n = 4). Furthermore, compared to control experiments VU0255035 significantly interacted with the carbachol induced LTD (2-way repeat measure ANOVA F(1,15) = 8.93, P = 0.009), due to an inhibition of the carbachol induced LTD (P < 0.01, Holm-Sidak's multiple comparisons test). Thus a M1 mAChR mediated LTD is also found in the adult mouse mPFC.
281 282 283 284 285 286 287 288 289 290 291 292 293 294 295
Adopting the same approach, we tested for a CB1R dependent mechanism with AM251. Incubating mPFC neurons in AM251 did not affect the acute depression induced by carbachol, however after washout responses recovered to baseline values indicating an inhibition of LTD (Figure 3D). Comparing individual experiments, fEPSPs 40 minutes after carbachol challenge were unchanged from baseline (101.2 ± 4.0 %, n = 6; Figure 3E). Furthermore, compared to control experiments, AM251 significantly interacted with the carbachol induced LTD (2-way repeat measure ANOVA F(1,15) = 7.37, P = 0.016), due to an inhibition of the carbachol induced LTD (P < 0.01, Holm-Sidak's multiple comparisons test). Expressing the LTD as a percent depression of baseline values, we compared the carbachol effect across treatments and identified a significant effect (one-way ANOVA F(3,24) = 3.82, P = 0.023; Figure 3F). Post-hoc analysis showed that treatment with either M1 mAChR antagonist or CB1R antagonist significantly reduced the induction of LTD compared to controls (Pirenzepine: P < 0.05; VU 0255,035: P < 0.05; AM251: P < 0.05; Holm-Sidak's multiple comparisons test). Therefore not only do mice share with rats an acetylcholine mediated form of LTD in the mPFC, but also the same M1 mAChR and CB1R dependent mechanism is engaged.
s i v o r P
8
l a n io
296
Coupling synaptic activity with endogenous release of acetylcholine results in mPFC LTD
297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326
Cholinergic afferents from the basal forebrain richly innervate the mPFC (Figure 1A). Therefore we asked if endogenous release of acetylcholine might also induce M1 mAChR mediated LTD. We adopted an optogenetic approach, using mice that selectively express channelrhodopsin in cholinergic neurons (ChR2:ACh mouse) and stimulated local acetylcholine release in the mPFC with a fiber optic. Previously, a 20 minute electrical paired-pulse 1 Hz protocol has proven successful in inducing M1 mAChR LTD in juvenile animals (Huang and Hsu, 2010; Volk et al., 2007). We adapted the same protocol to our light induced acetylcholine release experiments, stimulating paired-pulse release (50 ms interval) at 1 Hz for 20 minutes. However we found that light induced acetylcholine release alone did not cause a depression in responses from layer 5 neurons (Figure 4A). Field EPSPs 40 minutes after the stimulation protocol were not different from baseline values (100.5 ± 9.9 %, n = 5). A possible confounding issue in our light protocol is that compared to our carbachol protocol, there is no concurrent EPSP induction during the acetylcholine challenge. Hence, we wondered if coupling our light protocol with a single evoked EPSP timed to the second light pulse might permit LTD induction (Figure 4A, insert). We incubated our slices in the NMDAR antagonist D-AP5 (50 µM) to avoid any low frequency stimulation effects and repeated the 1 Hz paired-pulse protocol with a coincident EPSP. In this scenario we saw a strong depression of field EPSPs that persisted for the length of the recording (Figure 4A). On average responses as a percent of baseline were depressed to 75.3 ± 7.2 % (n = 11) 40 minutes after the coupled light EPSP protocol. We analyzed individual experiments before and after the protocol and found a significant depression in responses (Figure 4B; t(10) = 4.12, P = 0.002). Importantly when we repeated the same protocol without light induced acetylcholine release we failed to observe a depression of responses (fEPSP percent of baseline: 108.0 ± 3.0 %, n = 3). We compared the percent LTD in the ChR2:ACh mouse with light and/or evoked EPSP with a control ChR2 null mouse challenged with the same light - EPSP protocol and identified a significant effect (Figure 4C; one-way ANOVA F(3,20) = 4.73, P = 0.012). Post-hoc analysis indicated this was due to a significant depression in ChR2:ACh mice with the coupled light EPSP protocol that was not found in ChR2 null mice or in mice without coupled light and synaptic activity (P < 0.05, Holm-Sidak's multiple comparisons test). Thus the induction of endogenous acetylcholine mediated LTD in the mPFC requires the coupling of acetylcholine release with a coincident post-synaptic potential.
327 328 329 330 331 332 333 334 335 336 337 338 339
To confirm the same M1 mAChR LTD mechanism was engaged with release of endogenous acetylcholine, we repeated experiments in the presence of the M1 mAChR antagonist pirenzepine. The coupled light and EPSP protocol resulted in a small acute depression in field EPSP responses, however fEPSPs subsequently recovered such that 40 minutes after the protocol responses had returned to baseline (Figure 4D; Percent of baseline, pirenzepine: 100.7 ± 8.7 %, n = 5). Likewise we repeated experiments while antagonizing the CB1R with AM251. Again the coupled light and EPSP protocol induced a short depression of responses, however 40 minutes later responses recovered to baseline (Figure 4E; 101.1 ± 7.0 %, n = 6). Expressing responses 40 minutes after the coupled light and EPSP protocol as a percent LTD, we compared layer 5 mPFC LTD inductions across treatments (Figure 4F). The mean LTD was different between groups (one-way ANOVA F(2,19) = 5.44, P = 0.013) Post-hoc analysis confirmed that the presence of M1 mAChR or CB1R antagonists significantly inhibited the induction of LTD (P < 0.05, HolmSidak's multiple comparisons test). Therefore layer 5 neurons in the adult mPFC do expresses a
s i v o r P
9
l a n io
340 341
M1 mAChR and CB1R mediated LTD in response to endogenous acetylcholine release, but only conditionally with a synchronous EPSP.
342
Discussion
343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360
CB1R are highly expressed throughout the central nervous system, where they predominantly modulate neurotransmitter release at axonal terminals (Heifets and Castillo, 2009). Thus activating CB1Rs with endogenous or exogenous cannabinoids can dramatically affect synaptic function throughout the brain. In the prefrontal cortex CB1Rs are found at both inhibitory and excitatory synapses and are able to modulate both short-term and long-term synaptic depression (Auclair et al., 2000; Chiu et al., 2010; Fortin and Levine, 2007; Lafourcade et al., 2007; Yoshino et al., 2011). Notably layer 5 pyramidal neurons express an mGluR5 dependent eCB mediated LTD in response to native firing patterns, that is sensitive to disruption in many neuropathological conditions (Jung et al., 2012; Kasanetz et al., 2013; Lafourcade et al., 2007, 2011; Lovelace et al., 2014; Thomazeau et al., 2014). This mGluR5 – CB1R LTD is particularly relevant to the M1 mAChR LTD described here, since both mGluR5 and M1 AChRs couple to the same G-protein class (Gq/11), which via activation of PLC lead to the production of the eCB precursor diacylglycerol (Heifets and Castillo, 2009; Katona and Freund, 2012). Previous reports have linked activation of PLC to the induction of M1 mAChR mediated LTD in the mPFC (Caruana et al., 2011; Ghoshal et al., 2015; Huang and Hsu, 2010), however this is the first time a demonstration of a CB1R mediated mechanism has been made. Our findings suggest that activation of M1 mAChRs on layer 5 pyramidal neurons couples to local eCB mobilization leading to a CB1R mediated depression of glutamatergic neurotransmission.
361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376
Such a model is consistent with findings in both the hippocampus and striatum, where there is strong evidence of mAChR modulation of eCB signaling at inhibitory synapses. GABAergic synapses in the hippocampus and other brain areas express a short-term form of CB1R mediated synaptic plasticity termed depolarization-induced suppression of inhibition (DSI). Post-synaptic depolarization, either by experimenter induced voltage step or back-propagation of action potentials, engages a calcium dependent mobilization of eCBs that signal in a retrograde direction to presynaptic CB1Rs localized on GABAergic terminals (Kano et al., 2009). It is well established that low concentrations of carbachol potentiate DSI by enhancing eCB signaling independent of other mAChR ion channel-coupled mechanisms (Kim et al., 2002; Narushima et al., 2007; Ohno-Shosaku et al., 2003). Furthermore, engaging more vigorous DSI like protocols results in a CB1R mediated LTD at hippocampal inhibitory synapses (iLTD) that is also sensitive to mAChR activation (Younts et al., 2013). Equally at excitatory synapses that expresses eCB mediated LTD, evidence suggests that mAChR activation can either alone or with parallel synaptic activity induce CB1R mediated LTD (Colgin et al., 2003; Zhao and Tzounopoulos, 2011) Thus there is good evidence that the M1 mAChRs can engage the eCB system to induce CB1R mediated LTD.
377 378 379 380 381 382
Our experiments in both the adult rat and mouse mPFC suggest a robust engagement of the endocannbinoid system in response to direct pharmacological M1 mAChR activation and the induction of LTD. However these findings lie in contrast to a prior report studying M1 mAChR LTD in the juvenile mPFC, where the authors failed to find any CB1R dependence (Huang and Hsu, 2010). It is worth noting that there appear to be other differences present between juvenile and adult rats in the induction of M1 mAChR LTD. Experiments in the juvenile mPFC suggest a
s i v o r P
10
l a n io
383 384 385 386 387 388 389 390 391 392 393
lower sensitivity to carbachol challenge (Huang and Hsu, 2010). Furthermore at this developmental age the magnitude of M1 mAChR LTD is insensitive to the duration of carbachol challenge (Caruana et al., 2011), in contrast to the clear time – response dependency found here. Of relevance, the engagement of eCB mediated synaptic modulation appears to be developmentally regulated (Castillo et al., 2012). DSI at hippocampal synapses is absent at early postnatal periods in the rat and importantly synergy between DSI and mGluR activation only becomes significant during adolescence (Liang et al., 2014; Zhu and Lovinger, 2010). Relative to other brain areas the mPFC shows a delayed developmental trajectory and it is postulated that a critical window to synaptic plasticity opens only upon reaching adolescence in this brain region (Selemon, 2013). Thus it is possible that mAChR induced eCB mobilization is only present at the later developmental stages studied here.
394 395 396 397 398 399 400 401 402 403 404 405
In our hands, depression of glutamatergic synaptic transmission in the mPFC with carbachol challenge proceeds in two phases; an initial acute depression of transmission presumably mediated by presynaptic M2/M4 mAChR (Lucas-Meunier et al., 2003), followed by an extended LTD after wash off. Brief periods of carbachol challenge (5 minutes) that nonetheless resulted in acute synaptic depression, failed to induce mAChR LTD, whereas longer periods of carbachol challenge resulted in a robust LTD. This is directly comparable to stimulus evoked LTD, where a 10 minute 10 Hz protocol induces a robust CB1R mediated LTD, but a 5 minute protocol is subthreshold (Lafourcade et al., 2007; Marrs et al., 2010). Importantly both subthreshold stimulus evoked LTD and subthreshold mAChR LTD can be converted to LTD by reducing hydrolysis of the eCB 2-AG with inhibition of MAGL. This is consistent with the idea that mAChR LTD in the mPFC proceeds via 2-AG mediated mechanism, wherein post-synaptic synthesis of 2-AG signals to pre-synaptic CB1R to induce LTD.
406 407 408 409 410 411 412 413 414 415 416 417 418 419
Cholinergic fibers projecting from the basal forebrain richly innervate the mPFC (Houser et al., 1985), however their long trajectory and mixing with both GABAergic and glutamatergic fibers makes selective electrical stimulation of these inputs difficult in the slice. Therefore we pursued an optogenetic approach and used mice selectively expressing channelrhodopsin in cholinergic neurons and induced local mPFC acetylcholine release via a fiber optic. Such an approach has recently proven successful in the hippocampus where selective electrical activation of cholinergic fibers is also problematic (Alger et al., 2014). We stimulated cholinergic afferents with brief light pulses at a 20 Hz interval, similar to reported native beta oscillations found in the basal forebrain (Quinn et al., 2010; Tingley et al., 2015). Nevertheless, initial attempts to induce mAChR LTD with local acetylcholine release in isolation were unsuccessful. However, when we coupled phasic acetylcholine release with an EPSP, CB1R dependent LTD was observed. Neither EPSP induction alone nor repeating the protocol in channelrhodopsin null animals resulted in LTD. Thus the release of endogenous acetylcholine can induce LTD, but requisite of cooperative synaptic activity.
420 421 422 423 424 425 426
This requirement for concomitant glutamatergic synaptic and M1 mAChR activity likely reflects the subtle composition of the eCB system and its suitability to signal integration. With suprathreshold stimulation either Gq/11 coupled metabotropic receptors or post-synaptic calcium entry alone can induce eCB mobilization and synaptic depression, however by coupling subthreshold stimulations eCB LTD may equally be induced (Ohno-Shosaku and Kano, 2014). Notably in pyramidal neurons in the mPFC, M1 mAChR are enriched in spines, placing them well to coordinate synaptic activity (Yamasaki et al., 2010). Furthermore, the proposed coincidence
s i v o r P
11
l a n io
427 428 429 430
detector molecule, PLC (Hashimotodani et al., 2005), appears robustly activated in the mPFC during M1 mAChR challenge (Caruana et al., 2011; Huang and Hsu, 2010). Regardless of the precise mechanism our results suggest that endogenously released acetylcholine results in LTD only in neurons where there is corresponding glutamatergic synaptic activity.
431 432 433 434 435 436 437 438 439 440 441 442 443
How this form of LTD correlates with mPFC dependent learning and function is speculative. Cholinergic input to the mPFC has a prominent role in promoting attention via modulation of local cortical networks (Bloem et al., 2014; Hasselmo and Sarter, 2011; Klinkenberg et al., 2011), and the eCB system has been proposed to modulate associated cortical oscillations (Alger et al., 2014). However more specifically, there is accumulating evidence that cholinergic afferents transmit salient information to the neocortex, which may direct specific behaviors in the mPFC (Lin and Nicolelis, 2008; Parikh et al., 2007; Tingley et al., 2015). The eCB system seems well positioned to integrate glutamatergic and cholinergic neurotransmission at layer 5 glutamatergic synapses, be it a reflection of general cortical arousal or specific acetylcholine release. In this context it is interesting to note that modulation of the eCB system is a developing target for the treatment of Alzheimer’s disease, where enhancement of cholinergic signaling has long been a principal therapeutic (Aso and Ferrer, 2014). Thus it may be that targeting of the eCB system could compensate for deficits in cholinergic signaling found in this disorder.
444
Acknowledgements
445 446 447
The authors thank Joanne Palsma for help in electrophysiology recordings and Florence Jaouen for ChR2:ACh mouse breeding. We are grateful to Dr. P. Chavis, and the Manzoni and Chavis laboratories for helpful discussion.
448
Funding
449
INSERM, ANR CYFIP-Aut and Foundation Jêrome Lejeune (H.M.) supported this work.
450
Author Contributions
451 452 453
H.M., A.B., A.L.P. and O.J.M. designed research; H.M., A.B., C.B. and O.L. performed research; H.M., A.B and C.B. analyzed data; C.B contributed regent and methods, H.M. and O.J.M. wrote the paper; O.J.M. supervised the entire project. The authors declare no conflict of interest.
s i v o r P
l a n io
454 455
References
456 457 458
Alger, B. E., Nagode, D. A., and Tang, A.-H. (2014). Muscarinic cholinergic receptors modulate inhibitory synaptic rhythms in hippocampus and neocortex. Front. Synaptic Neurosci. 6, 18. doi:10.3389/fnsyn.2014.00018.
459 460 461
Anagnostaras, S. G., Murphy, G. G., Hamilton, S. E., Mitchell, S. L., Rahnama, N. P., Nathanson, N. M., et al. (2003). Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat. Neurosci. 6, 51–58. doi:10.1038/nn992.
12
462 463
Aso, E., and Ferrer, I. (2014). Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic. Front. Pharmacol. 5, 37. doi:10.3389/fphar.2014.00037.
464 465 466
Auclair, N., Otani, S., Soubrie, P., and Crepel, F. (2000). Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons. J. Neurophysiol. 83, 3287–3293.
467 468 469
Barker, G. R. I., and Warburton, E. C. (2009). Critical role of the cholinergic system for objectin-place associative recognition memory. Learn. Mem. 16, 8–11. doi:10.1101/lm.1121309.
470 471 472
Bloem, B., Poorthuis, R. B., and Mansvelder, H. D. (2014). Cholinergic modulation of the medial prefrontal cortex: the role of nicotinic receptors in attention and regulation of neuronal activity. Front. Neural Circuits 8, 17. doi:10.3389/fncir.2014.00017.
473 474 475 476
Carballo-Márquez, A., Vale-Martínez, A., Guillazo-Blanch, G., Torras-Garcia, M., Boix-Trelis, N., and Martí-Nicolovius, M. (2007). Differential effects of muscarinic receptor blockade in prelimbic cortex on acquisition and memory formation of an odor-reward task. Learn. Mem. Cold Spring Harb. N 14, 616–624. doi:10.1101/lm.597507.
477 478 479
Caruana, D. A., Warburton, E. C., and Bashir, Z. I. (2011). Induction of activity-dependent LTD requires muscarinic receptor activation in medial prefrontal cortex. J. Neurosci. 31, 18464–18478. doi:10.1523/jneurosci.4719-11.2011.
480 481
Castillo, P. E., Younts, T. J., Chávez, A. E., and Hashimotodani, Y. (2012). Endocannabinoid signaling and synaptic function. Neuron 76, 70–81. doi:10.1016/j.neuron.2012.09.020.
482 483 484
Chiu, C. Q., Puente, N., Grandes, P., and Castillo, P. E. (2010). Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J. Neurosci. 30, 7236–7248. doi:10.1523/jneurosci.0736-10.2010.
485 486 487
Colgin, L. L., Kramár, E. A., Gall, C. M., and Lynch, G. (2003). Septal modulation of excitatory transmission in hippocampus. J. Neurophysiol. 90, 2358–2366. doi:10.1152/jn.00262.2003.
488 489 490
Fortin, D. A., and Levine, E. S. (2007). Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb. Cortex 17, 163–174. doi:10.1093/cercor/bhj133.
491 492 493 494 495
Ghoshal, A., Rook, J. M., Dickerson, J. W., Roop, G. N., Morrison, R. D., Jalan-Sakrikar, N., et al. (2015). Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. doi:10.1038/npp.2015.189.
496 497
Gil, Z., Connors, B. W., and Amitai, Y. (1997). Differential regulation of neocortical synapses by neuromodulators and activity. Neuron 19, 679–686.
s i v o r P
13
l a n io
498 499 500 501
Hashimotodani, Y., Ohno-Shosaku, T., Tsubokawa, H., Ogata, H., Emoto, K., Maejima, T., et al. (2005). Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron 45, 257–268. doi:10.1016/j.neuron.2005.01.004.
502 503 504
Hasselmo, M. E., and Sarter, M. (2011). Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 36, 52–73. doi:10.1038/npp.2010.104.
505 506
Heifets, B. D., and Castillo, P. E. (2009). Endocannabinoid signaling and long-term synaptic plasticity. Annu. Rev. Physiol. 71, 283–306. doi:10.1146/annurev.physiol.010908.163149.
507 508 509 510
Houser, C. R., Crawford, G. D., Salvaterra, P. M., and Vaughn, J. E. (1985). Immunocytochemical localization of choline acetyltransferase in rat cerebral cortex: a study of cholinergic neurons and synapses. J. Comp. Neurol. 234, 17–34. doi:10.1002/cne.902340103.
511 512 513
Huang, C.-C., and Hsu, K.-S. (2010). Activation of Muscarinic Acetylcholine Receptors Induces a Nitric Oxide–Dependent Long-Term Depression in Rat Medial Prefrontal Cortex. Cereb. Cortex 20, 982–996. doi:10.1093/cercor/bhp161.
514 515 516
Jung, K.-M., Sepers, M., Henstridge, C. M., Lassalle, O., Neuhofer, D., Martin, H., et al. (2012). Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun. 3, 1080. doi:10.1038/ncomms2045.
517 518 519
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., and Watanabe, M. (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89, 309–380. doi:10.1152/physrev.00019.2008.
520 521 522
Kasanetz, F., Lafourcade, M., Deroche-Gamonet, V., Revest, J.-M., Berson, N., Balado, E., et al. (2013). Prefrontal synaptic markers of cocaine addiction-like behavior in rats. Mol. Psychiatry 18, 729–737. doi:10.1038/mp.2012.59.
523 524
Katona, I., and Freund, T. F. (2012). Multiple Functions of Endocannabinoid Signaling in the Brain. Annu. Rev. Neurosci. 35, 529–558. doi:10.1146/annurev-neuro-062111-150420.
525 526 527
Kim, J., Isokawa, M., Ledent, C., and Alger, B. E. (2002). Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci. 22, 10182–10191.
528 529
Klinkenberg, I., Sambeth, A., and Blokland, A. (2011). Acetylcholine and attention. Behav. Brain Res. 221, 430–442. doi:10.1016/j.bbr.2010.11.033.
530 531 532
Lafourcade, M., Elezgarai, I., Mato, S., Bakiri, Y., Grandes, P., and Manzoni, O. J. (2007). Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex. PLoS ONE 2, e709. doi:10.1371/journal.pone.0000709.
s i v o r P
14
l a n io
533 534 535
Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A., Sepers, M., Matias, I., et al. (2011). Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 14, 345–350. doi:10.1038/nn.2736.
536 537 538
Liang, S.-L., Alger, B. E., and McCarthy, M. M. (2014). Developmental increase in hippocampal endocannabinoid mobilization: role of metabotropic glutamate receptor subtype 5 and phospholipase C. J. Neurophysiol. 112, 2605–2615. doi:10.1152/jn.00111.2014.
539 540 541
Lin, S.-C., and Nicolelis, M. A. L. (2008). Neuronal ensemble bursting in the basal forebrain encodes salience irrespective of valence. Neuron 59, 138–149. doi:10.1016/j.neuron.2008.04.031.
542 543 544
Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., et al. (2009). Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol. 5, 37–44. doi:10.1038/nchembio.129.
545 546 547
Lovelace, J. W., Vieira, P. A., Corches, A., Mackie, K., and Korzus, E. (2014). Impaired fear memory specificity associated with deficient endocannabinoid-dependent long-term plasticity. Neuropsychopharmacology 39, 1685–1693. doi:10.1038/npp.2014.15.
548 549 550
Lucas-Meunier, E., Fossier, P., Baux, G., and Amar, M. (2003). Cholinergic modulation of the cortical neuronal network. Pflüg. Arch. Eur. J. Physiol. 446, 17–29. doi:10.1007/s00424002-0999-2.
551 552 553
Madisen, L., Mao, T., Koch, H., Zhuo, J., Berenyi, A., Fujisawa, S., et al. (2012). A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing. Nat. Neurosci. 15, 793–802. doi:10.1038/nn.3078.
554 555 556
Marrs, W. R., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., Coy, J., et al. (2010). The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat. Neurosci. 13, 951–957. doi:10.1038/nn.2601.
557 558 559
Martin, H. G. S., Lassalle, O., Brown, J. T., and Manzoni, O. J. (2015). Age-Dependent LongTerm Potentiation Deficits in the Prefrontal Cortex of the Fmr1 Knockout Mouse Model of Fragile X Syndrome. Cereb. Cortex N. Y. N 1991. doi:10.1093/cercor/bhv031.
560 561 562
Massey, P. V., Bhabra, G., Cho, K., Brown, M. W., and Bashir, Z. I. (2001). Activation of muscarinic receptors induces protein synthesis-dependent long-lasting depression in the perirhinal cortex. Eur. J. Neurosci. 14, 145–152.
563 564 565 566
Mezey, E., Tóth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., et al. (2000). Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U. S. A. 97, 3655–3660. doi:10.1073/pnas.060496197.
567 568
Narushima, M., Uchigashima, M., Fukaya, M., Matsui, M., Manabe, T., Hashimoto, K., et al. (2007). Tonic enhancement of endocannabinoid-mediated retrograde suppression of
s i v o r P
15
l a n io
569 570
inhibition by cholinergic interneuron activity in the striatum. J. Neurosci. 27, 496–506. doi:10.1523/JNEUROSCI.4644-06.2007.
571 572
Ohno-Shosaku, T., and Kano, M. (2014). Endocannabinoid-mediated retrograde modulation of synaptic transmission. Curr. Opin. Neurobiol. 29, 1–8. doi:10.1016/j.conb.2014.03.017.
573 574 575 576
Ohno-Shosaku, T., Matsui, M., Fukudome, Y., Shosaku, J., Tsubokawa, H., Taketo, M. M., et al. (2003). Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur. J. Neurosci. 18, 109–116.
577 578 579
Parikh, V., Kozak, R., Martinez, V., and Sarter, M. (2007). Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron 56, 141–154. doi:10.1016/j.neuron.2007.08.025.
580 581 582
Purves, D. et al (2001). Neuroscience. 2nd Revised edition edition. , eds. D. Purves, G. J. Augustine, D. Fitzpatrick, C. K. Lawrence, A.-S. Lamantia, J. O. McNamara, et al. Sunderland, Mass: Sinauer Associates Inc.,U.S.
583 584 585
Quinn, L. K., Nitz, D. A., and Chiba, A. A. (2010). Learning-dependent dynamics of betafrequency oscillations in the basal forebrain of rats. Eur. J. Neurosci. 32, 1507–1515. doi:10.1111/j.1460-9568.2010.07422.x.
586 587 588
Robbe, D., Kopf, M., Remaury, A., Bockaert, J., and Manzoni, O. J. (2002). Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. 99, 8384–8388. doi:10.1073/pnas.122149199.
589 590
Selemon, L. D. (2013). A role for synaptic plasticity in the adolescent development of executive function. Transl. Psychiatry 3, e238. doi:10.1038/tp.2013.7.
591 592 593
van der Stelt, M., Trevisani, M., Vellani, V., De Petrocellis, L., Schiano Moriello, A., Campi, B., et al. (2005). Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels. EMBO J. 24, 3026–3037. doi:10.1038/sj.emboj.7600784.
594 595 596
Thomazeau, A., Lassalle, O., Iafrati, J., Souchet, B., Guedj, F., Janel, N., et al. (2014). Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a. J. Neurosci. 34, 1138–1147. doi:10.1523/jneurosci.2852-13.2014.
597 598 599
Tingley, D., Alexander, A. S., Quinn, L. K., Chiba, A. A., and Nitz, D. A. (2015). Cell Assemblies of the Basal Forebrain. J. Neurosci. 35, 2992–3000. doi:10.1523/jneurosci.4432-14.2015.
600 601 602
Van der Zee, E. A., and Keijser, J. N. (2011). Localization of pre- and postsynaptic cholinergic markers in rodent forebrain: a brief history and comparison of rat and mouse. Behav. Brain Res. 221, 356–366. doi:10.1016/j.bbr.2010.11.051.
603 604
Volk, L. J., Pfeiffer, B. E., Gibson, J. R., and Huber, K. M. (2007). Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is
s i v o r P
16
l a n io
605 606
affected in fragile X syndrome mental retardation. J. Neurosci. 27, 11624–11634. doi:10.1523/JNEUROSCI.2266-07.2007.
607 608 609
Warburton, E. C., Koder, T., Cho, K., Massey, P. V., Duguid, G., Barker, G. R. I., et al. (2003). Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory. Neuron 38, 987–996.
610 611 612 613
Yamasaki, M., Matsui, M., and Watanabe, M. (2010). Preferential Localization of Muscarinic M1 Receptor on Dendritic Shaft and Spine of Cortical Pyramidal Cells and Its Anatomical Evidence for Volume Transmission. J. Neurosci. 30, 4408–4418. doi:10.1523/jneurosci.5719-09.2010.
614 615
Yizhar, O., Fenno, L. E., Davidson, T. J., Mogri, M., and Deisseroth, K. (2011). Optogenetics in neural systems. Neuron 71, 9–34. doi:10.1016/j.neuron.2011.06.004.
616 617 618 619
Yoshino, H., Miyamae, T., Hansen, G., Zambrowicz, B., Flynn, M., Pedicord, D., et al. (2011). Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J. Physiol. 589, 4857–4884. doi:10.1113/jphysiol.2011.212225.
620 621 622
Younts, T. J., Chevaleyre, V., and Castillo, P. E. (2013). CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses. J. Neurosci. 33, 13743–13757. doi:10.1523/jneurosci.0817-13.2013.
623 624 625
Zhao, Y., and Tzounopoulos, T. (2011). Physiological activation of cholinergic inputs controls associative synaptic plasticity via modulation of endocannabinoid signaling. J. Neurosci. 31, 3158–3168. doi:10.1523/jneurosci.5303-10.2011.
626 627 628
Zhu, P. J., and Lovinger, D. M. (2010). Developmental alteration of endocannabinoid retrograde signaling in the hippocampus. J. Neurophysiol. 103, 1123–1129. doi:10.1152/jn.00327.2009.
s i v o r P
629 630
17
l a n io
631
Figure legends
632 633 634 635 636 637 638 639
Figure 1. Cholinergic terminals expressing ChR2-EYFP richly innervate the mPFC in ChR2:ACh mice. (A) Fluorescent image of a projected confocal z-stack 20 µm thick from the prelimbic cortex of the ChR2:ACh mouse. Approximate cortical layer boundaries are indicated to the right. Insert: similar image from a control C57Bl/6J mouse mPFC section acquired with identical settings. (B) Example of a presumed bipolar local cholinergic interneuron in mPFC from ChR2:ACh mouse. Image represents projected confocal image of YFP signal from prelimbic cortex coronal section. Approximate layer boundaries are indicated to the left. Orientation markers: D, dorsal; V, ventral; M, medial; L, lateral; scale bar: 30 µm.
640 641 642 643 644 645 646 647 648 649 650 651
Figure 2. M1 mAChR dependent LTD is CB1R mediated in adult rat mPFC. (A) Time course of normalized field EPSPs during acute carbachol (10 µM, 10 minutes) stimulation in presence of M1 receptor antagonist VU0255035 (10 µM, n = 5; control, n = 17). (B) Individual experiments from control group (grey), pre (baseline) and post (40 minutes washout) carbachol treatment and in black group average (**P < 0.01). Below, example traces from baseline (black) and 40 minutes post (orange) carbachol treatment (scale bar: 5 ms, 0.1 mV). (C) Time course of normalized field EPSPs in presence of CB1R antagonist AM251 (4 µM, n = 8) during carbachol induced LTD. (D) pre and post carbachol field EPSPs for individual experiments (grey) and group average (green) in presence of AM251; pre and post carbachol example traces below. (E) Time course of normalized field EPSPs during carbachol induced LTD in presence of TRPV1 receptor antagonist AMG 9810 (3 µM, n = 9). (F) Summary bar chart of percent LTD 40 minutes after carbachol washout (*P < 0.05).
652 653 654 655 656 657 658 659 660 661 662 663 664 665
Figure 3. M1 mAChR dependent LTD is expressed in the presynapse and is mediated by the eCB 2-AG. (A) Time course of normalized EPSC in response to carbachol (10 µM, 10 minutes) from layer 5 principal neurons (y-axis: left; clear data points), co-plotted with paired-pulse ratio (50 ms interval) at indicated time points (y-axis: right; filled data points). (B) Plot of paired-pulse ratio from individual neurons (grey), before (baseline) and 20 minutes after (LTD) carbachol challenge; group averages superimposed (filled data points, n = 7, *P < 0.05). Example traces taken at the indicated time points (A) during baseline (†) and after LTD (#) shown above (scale bar: 20 ms, 50 pA). (C) Time – response plot of percent LTD resulting from 10 µM carbachol challenge for varying time periods. (D) Time course of normalized field EPSPs during subthreshold carbachol challenge (10 µM, 5 minutes) in presence of MAG lipase inhibitor JZL184 (1 µM, n = 4; control, n = 6). Insert: fEPSPs expressed as percent LTD 40 minutes after challenge. (E) Before-after responses from individual experiments (grey) of baseline (Pre) and 40 minutes after sub-threshold carbachol challenge (Post) in presence of JZL184; in yellow group average. Example traces below, pre carbachol (black) and post (orange; scale bar: 10 ms, 0.1 mV).
666 667 668 669 670 671 672 673
Figure 4. Adult mice show M1 mAChR dependent LTD in mPFC mediated by CB1R. (A) Time course of normalized field EPSPs in response to acute carbachol (10 µM, 10 minutes) stimulation in presence of M1 mAChR antagonist pirenzepine (0.5 µM, n = 6; control, n = 14). (B) Individual experiments (grey) and group average, pre (baseline) and post (40 minutes washout) carbachol treatment (**P < 0.01). Below, example traces pre (black) and post (orange) carbachol treatment (scale bar: 5 ms, 0.1 mV). (C) Similar plot with highly selective M1 mAChR antagonist VU0255035 treated group before (Pre) and after (Post) carbachol challenge; group averages in red (10 µM, n = 4). Below, example traces. (D) Time course showing normalized field EPSPs in
s i v o r P
18
l a n io
674 675 676 677
response to carbachol stimulation in presence of CB1R antagonist AM251 (4 µM, n = 6). (E) before-after carbachol challenge plot of individual experiments in presence of AM251, group average in green. Below, example traces. (F) Summary bar chart of percent LTD 40 minutes after carbachol washout (*P < 0.05).
678 679 680 681 682 683 684 685 686 687 688 689 690 691
Figure 5. Endogenously released acetylcholine coupled to excitatory synaptic activity induces CB1R mediated LTD in mouse mPFC. (A) Time course of normalized field EPSPs in ChR2:ACh mouse challenged with a coupled light – EPSP 1 Hz stimulation train (1200 pulses (blue bar), protocol above). Coupled light and EPSP time course (clear circles, n = 11), light alone without EPSP time course (grey, n = 5). (B) Normalized field EPSPs from individual experiments at baseline (Pre) and 40 minutes after (Post) light – EPSP stimulation protocol, in black group average (**P < 0.01). Above: example traces pre (black) and post (orange) light – EPSP protocol (scale bar: 5 ms, 0.1 mV). (C) Summary plot of percent LTD calculated 40 minutes after end of stimulation protocol (*P < 0.05). (D) ChR2:ACh mouse field EPSP time course challenged with light – EPSP stimulation protocol (blue bar) in presence of M1 mAChR antagonist pirenzepine (0.5 µM, n = 5). Example traces above, pre (black) and post (orange) stimulation protocol. (E) Time course showing field EPSPs in response to light/EPSP stimulation protocol in ChR2:ACh mouse in presence of CB1R antagonist AM251 (4 µM, n = 6). (F) Summary bar chart of percent LTD 40 minutes after light – EPSP stimulation protocol.
s i v o r P
19
l a n io
Figure 1.TIF
o r P
o i s i v
l a n
Figure 2.TIF
o r P
o i s i v
l a n
Figure 3.TIF
o r P
o i s i v
l a n
Figure 4.TIF
o r P
o i s i v
l a n
Figure 5.TIF
o r P
o i s i v
l a n
